User Community

Advertisement

Cari - BioQC
@cari-bioqc
Active Member
Joined: Jun 23, 2025
Last seen: Jun 23, 2025
Topics: 0 / Replies: 5
Reply
RE: Number of replicates

First of all, we need to consider that the samples we analyse are just that: samples that should represent something bigger, such as the process, the ...

10 months ago
Reply
RE: Robustness

Guidelines ICH Q2 and ICH Q14 specify that robustness testing is part of method development, although many companies make it part of the method valida...

10 months ago
Reply
RE: Analytical Target Profile

I fully underline the previous answer, and you can also bring it back to a simpler question: if you do not know what the purpose of the method will be...

10 months ago
Reply
RE: CRO or Dossier Holder responsible for Specification

In addition to the previous answer: the so-called sponsor, the license-holding pharmaceutical company, has the overall responsibility for the quality ...

10 months ago
Reply
RE: Potency Testing

By the number of vies, this is an important topic. However, we also see no responses so far, perhaps indicating the question is too general. Could you...

10 months ago

Advertisement

Advertisement

Advertisement